Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Ellen K. Ritchie, MD, David Cella, PhD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH

Blood (2019) 134 (Supplement_1): 1332.

https://doi.org/10.1182/blood-2019-123779

Published: 2019

Journal Articles

The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3 -Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

David Cella, PhD, Ellen K. Ritchie, MD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH

Blood (2019) 134 (Supplement_1): 3850.

https://doi.org/10.1182/blood-2019-123790

Published: 2019

Journal Articles

Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial

Sabina Chiaretti, MD PhD, Renato Bassan, MD, Antonella Vitale, MD, Loredana Elia, Bs, Alfonso Piciocchi, Cristina Puzzolo, PhD, Martina Canichella, MD, Felicetto Ferrara, MD, Monia Lunghi, MD PhD, Francesco Fabbiano, MD, Massimiliano Bonifacio, MD, Nicola Fracchiolla, Prassede Salutari, MD, Alessandra Mancino, Bs, Marco Vignetti, MD, Anna Guarini, PhD, Alessandro Rambaldi, MD, Robin Foà, MD

Blood (2019) 134 (Supplement_1): 740.

https://doi.org/10.1182/blood-2019-128759

Published: 2019

Journal Articles

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Blood (2019) 134 (12): 935–945.

https://doi.org/10.1182/blood.2018886960

Published: 2019

Includes: Supplemental data

Journal Articles

First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood (2017) 130 (Supplement 1): 99.

https://doi.org/10.1182/blood.V130.Suppl_1.99.99

Published: 2017

Journal Articles

Health Related Quality of Life of Long-Term Survivors of Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Chemotherapy

Fabio Efficace, PhD, Franco Mandelli, MD, Erika Borlenghi, MD, Massimo Breccia, MD, Alessandro Rambaldi, MD, Giorgina Specchia, MD, Francesco Rodeghiero, Monica Morselli, Francesco Fabbiano, MD, Nicola Cantore, Emanuele Angelucci, MD, Cecilia Caramatti, MD, Paolo Di Bartolomeo, MD, Giovanni Pizzolo, MD, Marco Vignetti, MD, Francesco Lo Coco, MD

Blood (2016) 128 (22): 2415.

https://doi.org/10.1182/blood.V128.22.2415.2415

Published: 2016

Journal Articles

Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study

Blood (2016) 128 (22): 2288.

https://doi.org/10.1182/blood.V128.22.2288.2288

Published: 2016

Journal Articles

A Population-Based Study of Chronic Myeloid Leukemia Treated with Imatinib in First Line

Blood (2016) 128 (22): 3076.

https://doi.org/10.1182/blood.V128.22.3076.3076

Published: 2016

Journal Articles

Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Updated Results and Refined Genetic-Based Prognostic Stratification

Blood (2015) 126 (23): 81.

https://doi.org/10.1182/blood.V126.23.81.81

Published: 2015

Journal Articles

Interventional Strategies to Contain Colonization and Infections Caused By Carbapenemase Producing Klebsiella Pneumonia in Haematological Malignancies

Alessandra Malato, MD PhD, Francesco Acquaviva, Rosaria Felice, MD, Silvana Magrin, MD, Maria Grazia Donà, Rosanna Scimè, MD, Stefania Tringali, MD, Baldi maria Teresa, MD, Francesco Fabbiano, MD

Blood (2014) 124 (21): 2647.

https://doi.org/10.1182/blood.V124.21.2647.2647

Published: 2014

Journal Articles

First Results of the Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients

Blood (2014) 124 (21): 797.

https://doi.org/10.1182/blood.V124.21.797.797

Published: 2014

Journal Articles

Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series

Uwe Platzbecker, MD, Giuseppe Avvisati, MD, Gerhard Ehninger, MD, Laura Cicconi, MD, Christian Thiede, MD, Felicetto Ferrara, MD, Sonia Maria Orlando, B.Sc., Marco Vignetti, MD, Giorgina Specchia, MD, Marco Sborgia, Eros Di Bona, MD, Massimo Breccia, MD, Elisa Cerqui, MD, Konstanze Döhner, MD, Walter Fiedler, MD, Marie von Lilienfeld-Toal, MD, Bernd Hertenstein, MD, Helmut R. Salih, MD, Mohammed Wattad, MD, Michael Lübbert, Christian H. Brandts, MD, Mathias Hänel, MD, Norbert Schmitz, MD, Hartmut Link, MDPhD, Mariadomenica Divona, B.Sc., Chiara Frairia, MD, Enrico Maria Pogliani, MD, Claudio Fozza, MD, Alfonso Maria D'Arco, MD, Nicola Di Renzo, MD, Agostino Cortelezzi, MD, Francesco Fabbiano, MD, Paola Fazi, MD, Johannes Kullmer, MD, Walter E. Aulitzky, MD, Stefan W. Krause, MD, Hans Salwender, MD, Kerstin Schäfer-Eckart, MD, Markus P. Radsak, MD, Arnold Ganser, Hartmut Döhner, MD, Sergio Amadori, MD, Franco Mandelli, MD, Richard F. Schlenk, MD, Francesco Lo-Coco, MD

Blood (2014) 124 (21): 12.

https://doi.org/10.1182/blood.V124.21.12.12

Published: 2014

Journal Articles

Management of Venous Thromboembolism (VTE) in Patients with Acute Leukemia: Results from a Multicenter Study

Mariasanta Napolitano, MDPhD, Luca Valore, MD, Giorgia Saccullo, MD, Alessandra Malato, MD PhD, Calogero Vetro, Maria Enza Mitra, MD, Alessandro Lucchesi, MD, Francesco Fabbiano, MD, Donato Mannina, MD, Alessandra Casuccio, MD, Maria Ilaria Del Principe, Anna Candoni, MD, Francesco Di Raimondo, Sergio Siragusa, MD

Blood (2014) 124 (21): 3688.

https://doi.org/10.1182/blood.V124.21.3688.3688

Published: 2014

Journal Articles

Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia

Alessandra Malato, MD, PhD, Francesco Acquaviva, Alessandra Santoro, PhD, Rosaria Felice, MD, Silvana Magrin, MD, Diamante Turri, MD, Rosanna Scimè, MD, Raimondo Di Bella, MD, Domenico Salemi, Francesco Fabbiano, MD

Blood (2013) 122 (21): 5039.

https://doi.org/10.1182/blood.V122.21.5039.5039

Published: 2013

Journal Articles

Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study

Mariasanta Napolitano, MD, Luca Valore, MD, Giorgia Saccullo, MD, Alessandra Malato, MD, PhD, Calogero Vetro, Maria Enza Mitra, MD, Alessandro Lucchesi, MD, Francesco Fabbiano, MD, Donato Mannina, MD, Alessandra Casuccio, MD, Francesco Di Raimondo, MD, Sergio Siragusa, MD

Blood (2013) 122 (21): 3890.

https://doi.org/10.1182/blood.V122.21.3890.3890

Published: 2013

Journal Articles

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

Blood (2013) 122 (21): 770.

https://doi.org/10.1182/blood.V122.21.770.770

Published: 2013

Journal Articles

Peripherally Inserted Central Catheters (PICCs) Can Be Successfully Utilized in Haematological Patients: Efficacy of an Educational Program.

Alessandra Malato, MD, PhD, Andrea Luppino, Raffaele Pipitone, Maria Grazia Donà, Francesco Acquaviva, Raimondo Di Bella, MD, Rosanna Scimè, MD, Francesco Fabbiano, MD

Blood (2012) 120 (21): 3161.

https://doi.org/10.1182/blood.V120.21.3161.3161

Published: 2012

Journal Articles

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

Blood (2011) 118 (23): 6153–6163.

https://doi.org/10.1182/blood-2011-07-365320

Published: 2011

Includes: Supplemental data

Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC

Blood (2011) 118 (21): 257.

https://doi.org/10.1182/blood.V118.21.257.257

Published: 2011

Journal Articles

Safety and Efficacy of An Educational Program in Reducing Complications of Peripherally Inserted Central Catheters (PICCs) in Haematological Patients,

Alessandra Malato, MD, PhD, Andrea Luppino, Sr., Raffaele Pipitone, Sr., Maria Grazia Donà, Sr., Francesco Acquaviva, Sr., Francesco Fabbiano, MD

Blood (2011) 118 (21): 4219.

https://doi.org/10.1182/blood.V118.21.4219.4219

Published: 2011

NARROW

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3 -Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Health Related Quality of Life of Long-Term Survivors of Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Chemotherapy

Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study

A Population-Based Study of Chronic Myeloid Leukemia Treated with Imatinib in First Line

Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Updated Results and Refined Genetic-Based Prognostic Stratification

Interventional Strategies to Contain Colonization and Infections Caused By Carbapenemase Producing Klebsiella Pneumonia in Haematological Malignancies

First Results of the Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients

Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series

Management of Venous Thromboembolism (VTE) in Patients with Acute Leukemia: Results from a Multicenter Study

Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia

Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

Peripherally Inserted Central Catheters (PICCs) Can Be Successfully Utilized in Haematological Patients: Efficacy of an Educational Program.

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

Safety and Efficacy of An Educational Program in Reducing Complications of Peripherally Inserted Central Catheters (PICCs) in Haematological Patients,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only